-
1
-
-
84866241386
-
Practice parameters for the management of colon cancer
-
Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012;55(8):831-843.
-
(2012)
Dis Colon Rectum
, vol.55
, Issue.8
, pp. 831-843
-
-
Chang, G.J.1
Kaiser, A.M.2
Mills, S.3
Rafferty, J.F.4
Buie, W.D.5
-
2
-
-
79956219437
-
Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence
-
de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol. 2011;18(6):1590-1598.
-
(2011)
Ann Surg Oncol
, vol.18
, Issue.6
, pp. 1590-1598
-
-
de Campos-Lobato, L.F.1
Stocchi, L.2
da Luz Moreira, A.3
-
3
-
-
84874421968
-
Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation?
-
Habr-Gama A, Gama-Rodrigues J, Perez RO. Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation? Dis Colon Rectum. 2013;56(2):264-266.
-
(2013)
Dis Colon Rectum
, vol.56
, Issue.2
, pp. 264-266
-
-
Habr-Gama, A.1
Gama-Rodrigues, J.2
Perez, R.O.3
-
4
-
-
47149099193
-
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation
-
Quah HM, Chou JF, Gonen M, et al. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008;113(1):57-64.
-
(2008)
Cancer
, vol.113
, Issue.1
, pp. 57-64
-
-
Quah, H.M.1
Chou, J.F.2
Gonen, M.3
-
5
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205-216.
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
6
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731-1740.
-
(2004)
N Engl J Med
, vol.351
, Issue.17
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
-
7
-
-
0030990974
-
Pathological features of rectal cancer after preoperative radiochemotherapy
-
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19-23.
-
(1997)
Int J Colorectal Dis
, vol.12
, Issue.1
, pp. 19-23
-
-
Dworak, O.1
Keilholz, L.2
Hoffmann, A.3
-
8
-
-
0029057685
-
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum
-
discussion 786-777
-
Chari RS, Tyler DS, Anscher MS, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg. 1995;221(6):778-786; discussion 786-777.
-
(1995)
Ann Surg
, vol.221
, Issue.6
, pp. 778-786
-
-
Chari, R.S.1
Tyler, D.S.2
Anscher, M.S.3
-
9
-
-
0035371029
-
Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer
-
Seong J, Cho JH, Kim NK, Min JS, Suh CO. Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer. Int J Radiat Oncol Biol Phys. 2001;50(2):435-439.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.50
, Issue.2
, pp. 435-439
-
-
Seong, J.1
Cho, J.H.2
Kim, N.K.3
Min, J.S.4
Suh, C.O.5
-
10
-
-
52649170847
-
Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum
-
discussion 1805-1796
-
Nair RM, Siegel EM, Chen DT, et al. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg. 2008;12(10):1797-1805; discussion 1805-1796.
-
(2008)
J Gastrointest Surg
, vol.12
, Issue.10
, pp. 1797-1805
-
-
Nair, R.M.1
Siegel, E.M.2
Chen, D.T.3
-
11
-
-
84867859732
-
Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer
-
Issa N, Murninkas A, Powsner E, Dreznick Z. Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer. World J Surg. 2012;36(10):2481-2487.
-
(2012)
World J Surg
, vol.36
, Issue.10
, pp. 2481-2487
-
-
Issa, N.1
Murninkas, A.2
Powsner, E.3
Dreznick, Z.4
-
12
-
-
78651474092
-
Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization
-
Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53(12):1692-1698.
-
(2010)
Dis Colon Rectum
, vol.53
, Issue.12
, pp. 1692-1698
-
-
Habr-Gama, A.1
Perez, R.O.2
Wynn, G.3
Marks, J.4
Kessler, H.5
Gama-Rodrigues, J.6
-
13
-
-
84872174958
-
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution
-
Perez RO, Habr-Gama A, Lynn PB, et al. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. Dis Colon Rectum. 2013;56(1):6-13.
-
(2013)
Dis Colon Rectum
, vol.56
, Issue.1
, pp. 6-13
-
-
Perez, R.O.1
Habr-Gama, A.2
Lynn, P.B.3
-
14
-
-
77951272418
-
Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
-
Hughes R, Harrison M, Glynne-Jones R. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy? Acta Oncol. 2010;49(3):378-381.
-
(2010)
Acta Oncol
, vol.49
, Issue.3
, pp. 378-381
-
-
Hughes, R.1
Harrison, M.2
Glynne-Jones, R.3
-
15
-
-
73049094430
-
Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil?
-
Nyasavajjala SM, Shaw AG, Khan AQ, Brown SR, Lund JN. Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil? Colorectal Dis. 2010;12(1):33-36.
-
(2010)
Colorectal Dis
, vol.12
, Issue.1
, pp. 33-36
-
-
Nyasavajjala, S.M.1
Shaw, A.G.2
Khan, A.Q.3
Brown, S.R.4
Lund, J.N.5
-
16
-
-
0036161040
-
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients
-
discussion 135-136
-
Hiotis SP, Weber SM, Cohen AM, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg. 2002;194(2):131-135; discussion 135-136.
-
(2002)
J Am Coll Surg
, vol.194
, Issue.2
, pp. 131-135
-
-
Hiotis, S.P.1
Weber, S.M.2
Cohen, A.M.3
-
17
-
-
84872226206
-
Tumor scatter after neoadjuvant therapy for rectal cancer: are we dealing with an invisible margin?
-
Hayden DM, Jakate S, Pinzon MC, et al. Tumor scatter after neoadjuvant therapy for rectal cancer: are we dealing with an invisible margin? Dis Colon Rectum. 2012;55(12):1206-1212.
-
(2012)
Dis Colon Rectum
, vol.55
, Issue.12
, pp. 1206-1212
-
-
Hayden, D.M.1
Jakate, S.2
Pinzon, M.C.3
-
18
-
-
0034728076
-
Surveillance after colorectal cancer resection
-
Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet. 2000;355(9201):395-399.
-
(2000)
Lancet
, vol.355
, Issue.9201
, pp. 395-399
-
-
Berman, J.M.1
Cheung, R.J.2
Weinberg, D.S.3
-
19
-
-
33645876797
-
Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer
-
Park YA, Lee KY, Kim NK, Baik SH, Sohn SK, Cho CW. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol. 2006;13(5):645-650.
-
(2006)
Ann Surg Oncol
, vol.13
, Issue.5
, pp. 645-650
-
-
Park, Y.A.1
Lee, K.Y.2
Kim, N.K.3
Baik, S.H.4
Sohn, S.K.5
Cho, C.W.6
-
20
-
-
13044263876
-
Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases
-
Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg. 1999;23(7):721-726.
-
(1999)
World J Surg
, vol.23
, Issue.7
, pp. 721-726
-
-
Park, Y.J.1
Park, K.J.2
Park, J.G.3
Lee, K.U.4
Choe, K.J.5
Kim, J.P.6
-
21
-
-
79955382480
-
C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management
-
Thirunavukarasu P, Sukumar S, Sathaiah M, et al. C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management. J Natl Cancer Inst. 2011;103(8):689-697.
-
(2011)
J Natl Cancer Inst
, vol.103
, Issue.8
, pp. 689-697
-
-
Thirunavukarasu, P.1
Sukumar, S.2
Sathaiah, M.3
-
22
-
-
78651399828
-
The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer
-
Jang NY, Kang SB, Kim DW, et al. The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. Dis Colon Rectum. 2011;54(2):245-252.
-
(2011)
Dis Colon Rectum
, vol.54
, Issue.2
, pp. 245-252
-
-
Jang, N.Y.1
Kang, S.B.2
Kim, D.W.3
-
23
-
-
0023256456
-
Prevalence of ras gene mutations in human colorectal cancers
-
Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327(6120):293-297.
-
(1987)
Nature
, vol.327
, Issue.6120
, pp. 293-297
-
-
Bos, J.L.1
Fearon, E.R.2
Hamilton, S.R.3
-
24
-
-
73349114941
-
KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial
-
Richman SD, Seymour MT, Chambers P, et al. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. J Clin Oncol. 2009;27(35):5931-5937.
-
(2009)
J Clin Oncol
, vol.27
, Issue.35
, pp. 5931-5937
-
-
Richman, S.D.1
Seymour, M.T.2
Chambers, P.3
-
25
-
-
79956298812
-
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
-
Van Cutsem E, Kohne CH, Lang I, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011;29(15):2011-2019.
-
(2011)
J Clin Oncol
, vol.29
, Issue.15
, pp. 2011-2019
-
-
Van Cutsem, E.1
Kohne, C.H.2
Lang, I.3
-
26
-
-
0141593677
-
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair
-
Wang L, Cunningham JM, Winters JL, et al. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res. 2003;63(17):5209-5212.
-
(2003)
Cancer Res
, vol.63
, Issue.17
, pp. 5209-5212
-
-
Wang, L.1
Cunningham, J.M.2
Winters, J.L.3
-
27
-
-
68149165771
-
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
-
Souglakos J, Philips J, Wang R, et al. Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer. 2009;101(3):465-472.
-
(2009)
Br J Cancer
, vol.101
, Issue.3
, pp. 465-472
-
-
Souglakos, J.1
Philips, J.2
Wang, R.3
-
28
-
-
84879619977
-
Clinicopathological relevance of BRAF mutations in human cancer
-
Pakneshan S, Salajegheh A, Smith RA, Lam AK. Clinicopathological relevance of BRAF mutations in human cancer. Pathology. 2013;45(4):346-356.
-
(2013)
Pathology
, vol.45
, Issue.4
, pp. 346-356
-
-
Pakneshan, S.1
Salajegheh, A.2
Smith, R.A.3
Lam, A.K.4
-
29
-
-
11144356831
-
Methylation changes in faecal DNA: a marker for colorectal cancer screening?
-
Muller HM, Oberwalder M, Fiegl H, et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet. 2004;363(9417):1283-1285.
-
(2004)
Lancet
, vol.363
, Issue.9417
, pp. 1283-1285
-
-
Muller, H.M.1
Oberwalder, M.2
Fiegl, H.3
-
30
-
-
0033587747
-
CpG island methylator phenotype in colorectal cancer
-
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681-8686.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, Issue.15
, pp. 8681-8686
-
-
Toyota, M.1
Ahuja, N.2
Ohe-Toyota, M.3
Herman, J.G.4
Baylin, S.B.5
Issa, J.P.6
-
31
-
-
33745541234
-
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
-
Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38(7):787-793.
-
(2006)
Nat Genet
, vol.38
, Issue.7
, pp. 787-793
-
-
Weisenberger, D.J.1
Siegmund, K.D.2
Campan, M.3
-
32
-
-
33644696421
-
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline
-
3rd, Somerfield MR, et al
-
Desch CE, Benson AB, 3rd, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23(33):8512-8519.
-
(2005)
J Clin Oncol
, vol.23
, Issue.33
, pp. 8512-8519
-
-
Desch, C.E.1
Benson, A.B.2
-
33
-
-
25144450546
-
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis
-
Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. Radiology. 2005;237(1):123-131.
-
(2005)
Radiology
, vol.237
, Issue.1
, pp. 123-131
-
-
Bipat, S.1
van Leeuwen, M.S.2
Comans, E.F.3
-
34
-
-
0028900197
-
CT for the evaluation of carcinomas in the colon and rectum
-
Thoeni RF, Rogalla P. CT for the evaluation of carcinomas in the colon and rectum. Semin Ultrasound CT MR. 1995;16(2):112-126.
-
(1995)
Semin Ultrasound CT MR
, vol.16
, Issue.2
, pp. 112-126
-
-
Thoeni, R.F.1
Rogalla, P.2
-
35
-
-
34547098116
-
Detection of recurrent rectal cancer with CT
-
Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol. 2007;17(8):2044-2054.
-
(2007)
MRI and PET/CT. Eur Radiol.
, vol.17
, Issue.8
, pp. 2044-2054
-
-
Schaefer, O.1
Langer, M.2
-
36
-
-
72249083700
-
Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases
-
Chun YS, Vauthey JN, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009;302(21):2338-2344.
-
(2009)
JAMA
, vol.302
, Issue.21
, pp. 2338-2344
-
-
Chun, Y.S.1
Vauthey, J.N.2
Boonsirikamchai, P.3
-
37
-
-
84874691266
-
Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab
-
Ricotta R, Vanzulli A, Moroni M, et al. Magnetic resonance imaging as an early indicator of clinical outcome in patients with metastatic colorectal carcinoma treated with cetuximab or panitumumab. Clin Colorectal Cancer. 2013;12(1):45-53.
-
(2013)
Clin Colorectal Cancer
, vol.12
, Issue.1
, pp. 45-53
-
-
Ricotta, R.1
Vanzulli, A.2
Moroni, M.3
-
38
-
-
84864739157
-
Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls
-
Koh DM, Blackledge M, Padhani AR, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol. 2012;199(2):252-262.
-
(2012)
AJR Am J Roentgenol
, vol.199
, Issue.2
, pp. 252-262
-
-
Koh, D.M.1
Blackledge, M.2
Padhani, A.R.3
-
39
-
-
80051550535
-
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study
-
Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18(8):2224-2231.
-
(2011)
Ann Surg Oncol
, vol.18
, Issue.8
, pp. 2224-2231
-
-
Lambregts, D.M.1
Vandecaveye, V.2
Barbaro, B.3
-
41
-
-
84879512726
-
Clinical Relevance of PET/CT positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation
-
Perez RO, Habr-Gama A, Sao Juliao GP, et al. Clinical Relevance of PET/CT positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation. Colorectal Dis. 2013 Jun;15(6):674-82.
-
(2013)
Colorectal Dis
, vol.15
, Issue.6
, pp. 674-682
-
-
Perez, R.O.1
Habr-Gama, A.2
Sao Juliao, G.P.3
-
42
-
-
33646471544
-
Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice
-
Ptok H, Marusch F, Meyer F, et al. Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice. Eur J Surg Oncol. 2006;32(4):420-425.
-
(2006)
Eur J Surg Oncol
, vol.32
, Issue.4
, pp. 420-425
-
-
Ptok, H.1
Marusch, F.2
Meyer, F.3
-
43
-
-
4444349883
-
Endoanal and endorectal ultrasound: applications in colorectal surgery
-
Rieger N, Tjandra J, Solomon M. Endoanal and endorectal ultrasound: applications in colorectal surgery. ANZ J Surg. 2004;74(8):671-675.
-
(2004)
ANZ J Surg
, vol.74
, Issue.8
, pp. 671-675
-
-
Rieger, N.1
Tjandra, J.2
Solomon, M.3
-
44
-
-
0032239710
-
Localization of the peritoneal reflection in the pelvis by endorectal ultrasound
-
Gerdes B, Langer P, Kopp I, Bartsch D, Stinner B. Localization of the peritoneal reflection in the pelvis by endorectal ultrasound. Surg Endosc. 1998;12(12):1401-1404.
-
(1998)
Surg Endosc
, vol.12
, Issue.12
, pp. 1401-1404
-
-
Gerdes, B.1
Langer, P.2
Kopp, I.3
Bartsch, D.4
Stinner, B.5
-
45
-
-
0033896171
-
Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopathologic changes
-
Gavioli M, Bagni A, Piccagli I, Fundaro S, Natalini G. Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopathologic changes. Dis Colon Rectum. 2000;43(8):1075-1083.
-
(2000)
Dis Colon Rectum
, vol.43
, Issue.8
, pp. 1075-1083
-
-
Gavioli, M.1
Bagni, A.2
Piccagli, I.3
Fundaro, S.4
Natalini, G.5
-
46
-
-
54049132444
-
Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation
-
Radovanovic Z, Breberina M, Petrovic T, Golubovic A, Radovanovic D. Accuracy of endorectal ultrasonography in staging locally advanced rectal cancer after preoperative chemoradiation. Surg Endosc. 2008;22(11):2412-2415.
-
(2008)
Surg Endosc
, vol.22
, Issue.11
, pp. 2412-2415
-
-
Radovanovic, Z.1
Breberina, M.2
Petrovic, T.3
Golubovic, A.4
Radovanovic, D.5
-
47
-
-
84055222282
-
Endoscopic ultrasound: current role and future perspectives in managing rectal cancer patients
-
Cartana ET, Parvu D, Saftoiu A. Endoscopic ultrasound: current role and future perspectives in managing rectal cancer patients. J Gastrointestin Liver Dis. 2011;20(4):407-413.
-
(2011)
J Gastrointestin Liver Dis
, vol.20
, Issue.4
, pp. 407-413
-
-
Cartana, E.T.1
Parvu, D.2
Saftoiu, A.3
-
48
-
-
33744942879
-
Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging
-
Kim JC, Kim HC, Yu CS, et al. Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging. Am J Surg. 2006;192(1):89-97.
-
(2006)
Am J Surg
, vol.192
, Issue.1
, pp. 89-97
-
-
Kim, J.C.1
Kim, H.C.2
Yu, C.S.3
-
49
-
-
33646122221
-
Three-dimensional endorectal ultrasound using a new freehand software program: results in 35 patients with rectal cancer
-
Giovannini M, Bories E, Pesenti C, Moutardier V, Lelong B, Delpero JR. Three-dimensional endorectal ultrasound using a new freehand software program: results in 35 patients with rectal cancer. Endoscopy. 2006;38(4):339-343.
-
(2006)
Endoscopy
, vol.38
, Issue.4
, pp. 339-343
-
-
Giovannini, M.1
Bories, E.2
Pesenti, C.3
Moutardier, V.4
Lelong, B.5
Delpero, J.R.6
-
50
-
-
40349113040
-
Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment
-
Lassau N, Chami L, Benatsou B, Peronneau P, Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol. 2007;17 Suppl 6:F89-98.
-
(2007)
Eur Radiol
, Issue.17 SUPPL.
-
-
Lassau, N.1
Chami, L.2
Benatsou, B.3
Peronneau, P.4
Roche, A.5
-
51
-
-
84863719944
-
Microvascular structure and perfusion imaging of colon cancer by means of contrast-enhanced ultrasonography
-
Onji K, Yoshida S, Tanaka S, et al. Microvascular structure and perfusion imaging of colon cancer by means of contrast-enhanced ultrasonography. Abdom Imaging. 2012;37(2):297-303.
-
(2012)
Abdom Imaging
, vol.37
, Issue.2
, pp. 297-303
-
-
Onji, K.1
Yoshida, S.2
Tanaka, S.3
-
52
-
-
84871195695
-
Successful Combination Therapy of Radical Liver Resection With 5-Fluorouracil/leucovorin, Oxaliplatin Plus Bevacizumab for Ascending Colon Cancer With Pulmonary and 43 Liver Metastases: Report of a Case
-
Ochiai T, Masuda T, Yagi M, et al. Successful Combination Therapy of Radical Liver Resection With 5-Fluorouracil/leucovorin, Oxaliplatin, Plus Bevacizumab for Ascending Colon Cancer With Pulmonary and 43 Liver Metastases: Report of a Case. Int Surg. 2012;97(1):6-13.
-
(2012)
Int Surg
, vol.97
, Issue.1
, pp. 6-13
-
-
Ochiai, T.1
Masuda, T.2
Yagi, M.3
-
53
-
-
84868198400
-
Meeting the biologic challenge of colorectal metastases
-
Wanebo HJ, LeGolvan M, Paty PB, et al. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis. 2012;29(7):821-839.
-
(2012)
Clin Exp Metastasis
, vol.29
, Issue.7
, pp. 821-839
-
-
Wanebo, H.J.1
LeGolvan, M.2
Paty, P.B.3
-
54
-
-
81455131170
-
A new classification scheme for recurrent or metastatic colon cancer after liver metastasectomy
-
Hsu YN, Lin JK, Chen WS, et al. A new classification scheme for recurrent or metastatic colon cancer after liver metastasectomy. J Chin Med Assoc. 2011;74(11):493-499.
-
(2011)
J Chin Med Assoc
, vol.74
, Issue.11
, pp. 493-499
-
-
Hsu, Y.N.1
Lin, J.K.2
Chen, W.S.3
-
55
-
-
84875368874
-
Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor
-
discussion 856-847
-
Egger ME, Cannon RM, Metzger TL, et al. Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg. 2013;216(4):845-856; discussion 856-847.
-
(2013)
J Am Coll Surg
, vol.216
, Issue.4
, pp. 845-856
-
-
Egger, M.E.1
Cannon, R.M.2
Metzger, T.L.3
-
56
-
-
84872185425
-
Selection for hepatic resection of colorectal liver metastases: expert consensus statement
-
Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15(2):91-103.
-
(2013)
HPB (Oxford)
, vol.15
, Issue.2
, pp. 91-103
-
-
Adams, R.B.1
Aloia, T.A.2
Loyer, E.3
Pawlik, T.M.4
Taouli, B.5
Vauthey, J.N.6
-
57
-
-
34447628527
-
Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma
-
Takahashi S, Nagai K, Saito N, et al. Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma. Jpn J Clin Oncol. 2007;37(3):186-192.
-
(2007)
Jpn J Clin Oncol
, vol.37
, Issue.3
, pp. 186-192
-
-
Takahashi, S.1
Nagai, K.2
Saito, N.3
-
58
-
-
84876767651
-
Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer
-
Neki K, Kawahara H, Watanabe K, Toyama Y, Akiba T, Yanaga K. Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer. Anticancer Res. 2013;33(4):1769-1772.
-
(2013)
Anticancer Res
, vol.33
, Issue.4
, pp. 1769-1772
-
-
Neki, K.1
Kawahara, H.2
Watanabe, K.3
Toyama, Y.4
Akiba, T.5
Yanaga, K.6
-
59
-
-
84859255611
-
A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?
-
Dalton RS, Velineni R, Osborne ME, et al. A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis. 2012;14(5):567-571.
-
(2012)
Colorectal Dis
, vol.14
, Issue.5
, pp. 567-571
-
-
Dalton, R.S.1
Velineni, R.2
Osborne, M.E.3
-
60
-
-
79952964146
-
Personalized colon cancer care in 2010
-
Catenacci DV, Kozloff M, Kindler HL, Polite B. Personalized colon cancer care in 2010. Semin Oncol. 2011;38(2):284-308.
-
(2011)
Semin Oncol
, vol.38
, Issue.2
, pp. 284-308
-
-
Catenacci, D.V.1
Kozloff, M.2
Kindler, H.L.3
Polite, B.4
-
61
-
-
0035018397
-
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal
-
Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8(4):347-353.
-
(2001)
Ann Surg Oncol
, vol.8
, Issue.4
, pp. 347-353
-
-
Adam, R.1
Avisar, E.2
Ariche, A.3
-
62
-
-
57849117384
-
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1 1)
-
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-247.
-
(2009)
Eur J Cancer
, vol.45
, Issue.2
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
-
63
-
-
84869231718
-
Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?
-
Engin G, Sharifov R, Gural Z, et al. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? Diagn Interv Radiol. 2012;18(6):574-581.
-
(2012)
Diagn Interv Radiol
, vol.18
, Issue.6
, pp. 574-581
-
-
Engin, G.1
Sharifov, R.2
Gural, Z.3
|